Hypofractionated Palliative Radiation Therapy With Concurrent Chemotherapy for Advanced Head-and-Neck Cancer: The QUAD-Shot Regimen

Phase 1 Clinical Trial of Re-irradiation With Pemetrexed and Erlotinib Followed by Maintenance Erlotinib for Patients With Recurrent and Second Primary Squamous Cell Carcinoma of the Head and Neck Management of Recurrent Head-and-Neck Squamous Cell Carcinoma M. Porosnicu, K.M. Greven, C.A. Sullivan, J.D. Waltonen, R. Plasser Rouchard, and J.D. Browne; Wake Forest University School of Medicine, Winston-Salem, NC